2026 MIPS Improvement Activity IA_PSPA_26: Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event
Written by Tucker Deyett, Dedicated Advisor, ReportingMD. Source data: CMS Quality Payment Program 2026 measure specifications and benchmark files.
Subcategory: Patient Safety and Practice Assessment
At a glance
IA_PSPA_26, Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event, is a 2026 MIPS improvement activity in the Patient Safety and Practice Assessment subcategory. For PY2026 activities are not weighted: clinicians with small practice, rural, non-patient-facing, or HPSA status attest to one activity, all other Traditional MIPS participants attest to two, and MVP participants attest to one.
Activity description
A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patient’s primary care clinician regarding both the unscheduled visit and the nature of the adverse drug event within 48 hours. A clinically significant adverse event is defined as a medication-related harm or injury such as side-effects, supratherapeutic effects, allergic reactions, laboratory abnormalities, or medication errors requiring urgent/emergent evaluation, treatment, or hospitalization.
Activity details
- Activity ID: IA_PSPA_26
- Subcategory: Patient Safety and Practice Assessment
- Programs: Traditional MIPS, APP, APP Plus
- First performance year: 2018
Need help with IA_PSPA_26?
ReportingMD is a CMS qualified registry and healthcare data pipe with a 100% submission rate since 2001. We confirm IA attestations and documentation with every client before submission. Talk to a ReportingMD advisor or browse the full 2026 MIPS directory.